ORF7 of varicella-zoster virus is a neurotropic factor
- PMID: 22674980
- PMCID: PMC3421744
- DOI: 10.1128/JVI.00128-12
ORF7 of varicella-zoster virus is a neurotropic factor
Abstract
Varicella-zoster virus (VZV) is the causative agent of chickenpox and herpes zoster (shingles). After the primary infection, the virus remains latent in sensory ganglia and reactivates upon weakening of the cellular immune system due to various conditions, erupting from sensory neurons and infecting the corresponding skin tissue. The current varicella vaccine is highly attenuated in the skin and yet retains its neurovirulence and may reactivate and damage sensory neurons. The factors involved in neuronal invasion and establishment of latency are still elusive. Previously, we constructed a library of whole-gene deletion mutants carrying a bacterial artificial chromosome sequence and a luciferase marker in order to perform a comprehensive VZV genome functional analysis. Here, screening of dispensable gene deletion mutants in differentiated neuronal cells led to the identification of ORF7 as the first known, likely a main, VZV neurotropic factor. ORF7 is a virion component localized to the Golgi compartment in infected cells, whose deletion causes loss of polykaryon formation in epithelial cell culture. Interestingly, ORF7 deletion completely abolishes viral spread in human nervous tissue ex vivo and in an in vivo mouse model. This finding adds to our previous report that ORF7 is also a skin-tropic factor. The results of our investigation will not only lead to a better understanding of VZV neurotropism but could also contribute to the development of a neuroattenuated vaccine candidate against shingles or a vector for delivery of other antigens.
Figures
Similar articles
-
ORF7 of Varicella-Zoster Virus Is Required for Viral Cytoplasmic Envelopment in Differentiated Neuronal Cells.J Virol. 2017 May 26;91(12):e00127-17. doi: 10.1128/JVI.00127-17. Print 2017 Jun 15. J Virol. 2017. PMID: 28356523 Free PMC article.
-
Varicella-zoster virus neurotropism in SCID mouse-human dorsal root ganglia xenografts.Curr Top Microbiol Immunol. 2010;342:255-76. doi: 10.1007/82_2009_8. Curr Top Microbiol Immunol. 2010. PMID: 20225014 Review.
-
Varicella-zoster virus glycoprotein E is a critical determinant of virulence in the SCID mouse-human model of neuropathogenesis.J Virol. 2011 Jan;85(1):98-111. doi: 10.1128/JVI.01902-10. Epub 2010 Oct 20. J Virol. 2011. PMID: 20962081 Free PMC article.
-
Investigation of varicella-zoster virus neurotropism and neurovirulence using SCID mouse-human DRG xenografts.J Neurovirol. 2011 Dec;17(6):570-7. doi: 10.1007/s13365-011-0066-x. Epub 2011 Dec 8. J Neurovirol. 2011. PMID: 22161683 Review.
-
Neuronal Subtype and Satellite Cell Tropism Are Determinants of Varicella-Zoster Virus Virulence in Human Dorsal Root Ganglia Xenografts In Vivo.PLoS Pathog. 2015 Jun 19;11(6):e1004989. doi: 10.1371/journal.ppat.1004989. eCollection 2015 Jun. PLoS Pathog. 2015. PMID: 26090802 Free PMC article.
Cited by
-
New intranasal and injectable gene therapy for healthy life extension.Proc Natl Acad Sci U S A. 2022 May 17;119(20):e2121499119. doi: 10.1073/pnas.2121499119. Epub 2022 May 10. Proc Natl Acad Sci U S A. 2022. PMID: 35537048 Free PMC article.
-
Low Trend for VZV-Associated Disease Patients to Visit Neurologists.J Multidiscip Healthc. 2023 May 16;16:1379-1392. doi: 10.2147/JMDH.S412398. eCollection 2023. J Multidiscip Healthc. 2023. PMID: 37215749 Free PMC article.
-
Rational Design of a Skin- and Neuro-Attenuated Live Varicella Vaccine: A Review and Future Perspectives.Viruses. 2022 Apr 20;14(5):848. doi: 10.3390/v14050848. Viruses. 2022. PMID: 35632591 Free PMC article. Review.
-
Current In Vivo Models of Varicella-Zoster Virus Neurotropism.Viruses. 2019 May 31;11(6):502. doi: 10.3390/v11060502. Viruses. 2019. PMID: 31159224 Free PMC article. Review.
-
A novel recombinant ORF7-siRNA delivered by flexible nano-liposomes inhibits varicella zoster virus infection.Cell Biosci. 2023 Sep 12;13(1):167. doi: 10.1186/s13578-023-01108-1. Cell Biosci. 2023. PMID: 37700336 Free PMC article.
References
-
- Abendroth A, Arvin A. 1999. Varicella-zoster virus immune evasion. Immunol. Rev. 168:143–156 - PubMed
-
- Arvin AM. 1995. Aspects of the host response to varicella-zoster virus: a review of recent observations. Neurology 45:S36–S37 - PubMed
-
- Arvin AM. 2006. Investigations of the pathogenesis of varicella zoster virus infection in the SCIDhu mouse model. Herpes 13:75–80 - PubMed
-
- Arvin AM. 2001. Varicella-zoster virus, p 2731–2767 In Knipe DM, et al. (ed), Fields virology, 4th ed, vol 2 Lippincott Williams & Wilkins, Philadelphia, PA
-
- Arvin AM. 2001. Varicella-zoster virus: molecular virology and virus-host interactions. Curr. Opin. Microbiol. 4:442–449 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
